Issue 4/2008

The role of vascular endothelial growth factors and their receptors in malignant melanomas (273 — 279)

S. BRYCHTOVA, M. BEZDEKOVA, T. BRYCHTA, M. TICHY

Reduction of genotoxic effects of N-nitrosomorpholine in human hepatoma cells and hamster lung cells by carboxymethyl chitin-glucan (280 — 285)

D. SLAMENOVA, M. SRAMKOVA, I. CHALUPA, J. SMIGOVA, G. KOGAN

v-Myb suppresses phorbol ester- and modifies retinoic acid-induced differentiation of human promonocytic U937 cells (286 — 293)

L. KNOPFOVA, J. SMARDA

Influence of chemotherapy to hormonal levels in postmenopausal breast cancer patients (294 — 298)

O. PRIBYLOVA, D. SPRINGER, A. SVOBODNIK, M. KYR, T. ZIMA, L. PETRUZELKA

Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers (299 — 304)

E. CETIN, B. CENGIZ, E. GUNDUZ, M. GUNDUZ, H. NAGATSUKA, L. BEKIR-BEDER, K. FUKUSHIMA, D. PEHLIVAN, M. OZASLAN, N. YAMANAKA, K. NISHIZAKI, K. SHIMIZU, N. NAGAI

Effect of brefeldin A on membrane localization of MUC1 mucin and adhesive properties of cancer cells (305 — 311)

H. POROWSKA, A. PASZKIEWICZ-GADEK, D. LEMANCEWICZ, T. BIELAWSKI, S. WOŁCZYNSKI

Cytotoxicity of hydroxyapatite, fluorapatite and fluor-hydroxyapatite: a comparative in vitro study (312 — 316)

M. THEISZOVA, S. JANTOVA, S. LETASIOVA, M. PALOU, L. CIPAK

Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA (317 — 322)

F. JANKU, J. SROVNAL, G. KORINKOVA, J. NOVOTNY, L. PETRUZELKA, D. POWER, B. MATOUS, M. HAJDUCH

Expression of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship with angiogenesis (323 — 329)

Z. KE, X. ZHANG, L. MA, L. WANG

Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study (330 — 337)

T. FARKASOVA, S. GURSKA, V. WITKOVSKY, A. GABELOVA

Cytotoxicity of copper(II) complexes of N-salicylidene-L-glutamate: modulation by ascorbic acid (338 — 344)

H. PAULIKOVA, E. KADLECIKOVA, M. SUCHANOVA, Z. VALKOVA, P. RAUKO, D. HUDECOVA, A. VALENT

Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma (345 — 349)

M. ZEMANOVA, V. SCUDLA, Z. ADAM, E. GREGORA, L. POUR, J. MINARIK, P. PAVLICEK, T. PIKA, J. BACOVSKY

Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis (350 — 355)

L. SLOVACEK, B. SLOVACKOVA, V. PAVLIK, Z. HRSTKA, Z. MACINGOVA, L. JEBAVY, J. M. HORACEK

Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic (356 — 368)

L. DUSEK, J. ABRAHAMOVA, R. LAKOMY, R. VYZULA, J. KOPTIKOVA, T. PAVLIK, J. MUZIK, D. KLIMES